The beginning of the clinical trial plan of cell therapy (immuno cell therapy) in patients with covid 19

Considering the high potential of new methods of gene therapy and cell therapy in the treatment of various diseases such as monogenic disorders, autoimmune diseases, cancer, etc., the researchers of the Middle East Gene Therapy Company, in cooperation with the medical staff of Imam Khomeini Hospital, conducted a clinical trial of the immunocell therapy plan. they started

In this method, a special type of immune cell called Natural Killer (N.K cell) is used. These cells are extracted from the blood of a healthy person and injected into a patient with Covid-19. In this plan, patients receive different doses of cells. they receive at regular intervals and their disease status and symptoms are observed throughout this period and after that.

Today, cell therapy is being studied and investigated in many clinical researches around the world as an effective treatment method. In this method, different cells that are selected depending on the type of disease are used to perform a specific function in the affected area, which leads to Eliminating or reducing the symptoms of the disease.

Although this project is in its early stages, it is highly hoped that these cells will produce the desired therapeutic effects, especially in the lung tissue, and cause a complete recovery of the person.